BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Singapore
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:+08
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251203
DTEND;VALUE=DATE:20251204
DTSTAMP:20260508T004130
CREATED:20251123T185516Z
LAST-MODIFIED:20251123T190312Z
UID:10000393-1764720000-1764806399@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Prostate Cancer 2025
DESCRIPTION:The ESMO Guidelines: Real World Cases – Prostate Cancer 2025 is a one-hour live virtual webinar held by the European Society for Medical Oncology (ESMO) on December 3\, 2025\, at 18:30 CET. Its goal is to disseminate and critically review the updated ESMO Clinical Practice Guidelines for prostate cancer by applying them to a detailed\, real-world clinical case\, focusing on optimal treatment sequencing and the integration of novel therapies. \nThe session is targeted at all healthcare professionals working in Oncology\, and live viewers will be awarded a certificate of attendance and 1 ESMO-MORA category 1 point. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-415049
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/esmo.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251203
DTEND;VALUE=DATE:20251205
DTSTAMP:20260508T004130
CREATED:20251122T002130Z
LAST-MODIFIED:20251122T002146Z
UID:10000387-1764720000-1764892799@oncodaily.com
SUMMARY:ESMO Preceptorship on Gastric Cancer 2025: Singapore
DESCRIPTION:The ESMO Preceptorship on Gastric Cancer 2025: Singapore is an intensive two-day educational event focused on the multidisciplinary management of gastric and gastro-esophageal junction (GEJ) cancers. \nScheduled for December 3–4\, 2025\, in Singapore\, Republic of Singapore\, the program is designed to cover topics ranging from the fundamentals of epidemiology and molecular factors to best clinical practices in surgical\, adjuvant\, and metastatic settings. The course aims to teach participants to compare various approaches\, manage special situations and side effects\, and learn about novel treatment targets. This event is accredited with 9 ESMO-MORA category 1 points.
URL:https://oncodaily.com/event/preceptorship-on-gastric-cancer-414098
LOCATION:Singapore\, Republic of Singapore
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/GwEIvRVWcAAI2Ci.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251203
DTEND;VALUE=DATE:20251205
DTSTAMP:20260508T004130
CREATED:20251122T003001Z
LAST-MODIFIED:20251122T003025Z
UID:10000388-1764720000-1764892799@oncodaily.com
SUMMARY:ESMO Preceptorship on Breast Cancer 2025: Singapore
DESCRIPTION:The ESMO Preceptorship on Breast Cancer 2025: Singapore is a two-day educational event focused on various aspects of breast cancer management\, co-chaired by Rebecca Dent and Matteo Lambertini. \nScheduled for December 3–4\, 2025\, in Singapore\, Republic of Singapore\, the program aims to provide comprehensive learning on screening\, diagnosis\, genetic testing\, the biology of the disease\, and the crucial role of multidisciplinary care in managing early\, locally advanced\, and metastatic breast cancer across surgical\, radiation\, and systemic therapy settings. The course is accredited with 10 ESMO-MORA category 1 points
URL:https://oncodaily.com/event/preceptorship-on-breast-cancer-414103
LOCATION:Singapore\, Republic of Singapore
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/16_9.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251205T080000
DTEND;TZID=America/Halifax:20251207T170000
DTSTAMP:20260508T004130
CREATED:20250624T132413Z
LAST-MODIFIED:20250624T132433Z
UID:10000204-1764921600-1765126800@oncodaily.com
SUMMARY:ESMO Asia Congress 2025
DESCRIPTION:ESMO Asia Congress 2025 will be held from December 5-7\, 2025 at Singapore\, Republic of Singapore. \nThe congress serves as a vital platform to advance cancer care through the latest scientific discoveries\, innovative therapies\, and evolving clinical practices. Whether you’re a clinician\, researcher\, or healthcare provider\, this gathering offers a front-row seat to the future of oncology. \nCongress Officers for ESMO Asia Congress 2025 are Fabrice André\, Do-Youn Oh\, Sjoukje Oosting\, Arun Azad\, and Nadia Harbeck. \nAttendees can expect a rich and diverse programme featuring plenary lectures\, multidisciplinary tumour boards\, “Meet the Expert” sessions\, and poster presentations\, all designed to promote cross-disciplinary learning and collaboration. With a strong emphasis on clinical excellence and global perspectives\, ESMO Asia fosters a vibrant exchange of knowledge\, helping to shape cancer treatment strategies tailored to the region’s unique challenges. \nMark your calendar for this transformative event in Singapore\, where science meets practice to improve patient outcomes. \nRegistration is Open for The Event. \n 
URL:https://oncodaily.com/event/esmo-asia-congress-2025-317714
LOCATION:Suntec Singapore Convention & Exhibition Centre\, 1 Raffles Boulevard Singapore\, Singapore\, 039593\, Singapore
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/06/download-7-Picsart-AiImageEnhancer-1.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251208
DTEND;VALUE=DATE:20251210
DTSTAMP:20260508T004130
CREATED:20251130T151257Z
LAST-MODIFIED:20251130T151257Z
UID:10000426-1765152000-1765324799@oncodaily.com
SUMMARY:ESMO Preceptorship on NSCLC and SCLC 2025: Singapore
DESCRIPTION:The ESMO Preceptorship on NSCLC and SCLC 2025 in Singapore\, taking place from 8 December 2025 to 9 December 2025\, brings together oncology professionals to explore best practices in managing non-small-cell and small-cell lung cancer across all stages. \nThe programme covers the latest in targeted therapies\, actionable driver alterations\, immune checkpoint blockade\, novel immunotherapies\, and systemic treatment of SCLC and pleural mesothelioma. Accredited with 10 ESMO-MORA category 1 points\, the preceptorship offers participants hands-on learning\, expert insights\, and a travel grant for non-local attendees to support participation.
URL:https://oncodaily.com/event/418939
LOCATION:The Orchard Singapore Hotel\, 442 Orchard Road\, Singapore\, 238879\, Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/BeFunky-collage-2025-11-30T191149031-Picsart-AiImageEnhancer.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251210
DTEND;VALUE=DATE:20251211
DTSTAMP:20260508T004130
CREATED:20251123T193232Z
LAST-MODIFIED:20251123T193250Z
UID:10000395-1765324800-1765411199@oncodaily.com
SUMMARY:ESMO Virtual Journal Club: December 2025
DESCRIPTION:The ESMO Virtual Journal Club: December 2025 is a one-hour virtual educational event exclusively for ESMO Members\, scheduled for Wednesday\, December 10\, 2025\, at 18:30 CET. \nChaired by Dr. Anna Campbell\, the Journal Club aims to enhance the understanding and application of the latest research in oncology by focusing on and critically evaluating two newly published studies: “Structured Exercise after Adjuvant Chemotherapy in Colon Cancer (CHALLENGE)” and “Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer.” Live attendees will receive a certificate of attendance and 1 ESMO-MORA category 1 point. \nRegister.
URL:https://oncodaily.com/event/esmo-virtual-journal-club-415070
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/ESMO-1-1.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251210T080000
DTEND;TZID=Europe/London:20251212T170000
DTSTAMP:20260508T004130
CREATED:20250701T130014Z
LAST-MODIFIED:20250701T130110Z
UID:10000206-1765353600-1765558800@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2025
DESCRIPTION:The ESMO Immuno-Oncology Congress 2025 will be held from 10 to 12 December 2025 as a hybrid event\, both onsite in London\, UK\, and online. This leading international congress brings together experts from around the globe to explore the full spectrum of immuno-oncology from basic science and translational research to clinical advancements. Attendees can expect cutting-edge sessions\, in-depth learning opportunities\, and dynamic networking with peers\, researchers\, and industry leaders. \nThe programme includes immersion sessions focused on immunobiology and translational insights\, updates on checkpoint inhibitor-based therapies\, and the latest in immune modulation including tumour microenvironment\, immunometabolism\, and cell signaling. Participants will also engage with industry and independent investigators to explore developments in cellular therapies\, cancer vaccines\, intratumoural immunotherapy\, and multispecific constructs. \nWhether attending in person or online\, the congress offers a valuable platform to share research\, expand knowledge\, and shape the future of cancer immunotherapy. \nRegistration is Open for the Event. \nMore posts featuring ESMO.
URL:https://oncodaily.com/event/esmo-immuno-oncology-congress-2025-321830
LOCATION:Queen Elizabeth II Centre in London\, United Kingdom\, Broad Sanctuary\, London SW1P 3EE\, London\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_6227.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251210T083000
DTEND;TZID=America/Halifax:20251210T120000
DTSTAMP:20260508T004130
CREATED:20251206T001840Z
LAST-MODIFIED:20251206T001927Z
UID:10000455-1765355400-1765368000@oncodaily.com
SUMMARY:ESMO-IO SITC Primer Program
DESCRIPTION:The ESMO-IO SITC Primer Program is a joint educational event organized by the European Society for Medical Oncology (ESMO) and the Society for Immunotherapy of Cancer (SITC)\, scheduled for December 10\, 2025\, from 8:30 a.m. to 12:00 p.m. BST. \nThis half-day primer\, held at the Queen Elizabeth II Centre in London\, UK\, focuses on fundamental immuno-oncology (IO) concepts. \nThe program will cover current and emerging topics in immuno-oncology (IO)\, including neoadjuvant immunotherapy\, intratumoral immunotherapies\, recombinant cytokines\, and bispecific antibodies\, alongside new applications of AI\, spatial biology\, and multiomic approaches.
URL:https://oncodaily.com/event/esmo-422513
LOCATION:Queen Elizabeth II Centre in London\, United Kingdom\, Broad Sanctuary\, London SW1P 3EE\, London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMOSITC.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251213
DTEND;VALUE=DATE:20251215
DTSTAMP:20260508T004130
CREATED:20251124T212249Z
LAST-MODIFIED:20251124T212304Z
UID:10000398-1765584000-1765756799@oncodaily.com
SUMMARY:Best of ESMO India 2025
DESCRIPTION:The Best of ESMO India 2025 is an ESMO-licensed event making its Indian debut in Mumbai\, scheduled for December 13–14\, 2025. \nThis conference\, hosted by the Global Healthcare Academy (GHA)\, is a major platform for disseminating the most recent\, cutting-edge data and clinical practices from the main European Society for Medical Oncology (ESMO) Congress. \nDesigned for a multidisciplinary audience including medical\, surgical\, and radiation oncologists\, the event will feature focus sessions guided by an extensive advisory\, core\, and scientific committee comprising leading Indian oncologists\, and will be held at The St. Regis Mumbai. \nRegister.
URL:https://oncodaily.com/event/best-of-esmo-india-415818
LOCATION:The St. Regis Mumbai\, 462 Senapati Bapat Marg\, Lower Parel\, Mumbai\, Maharashtra\, 400013\, India
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251216
DTEND;VALUE=DATE:20251218
DTSTAMP:20260508T004130
CREATED:20251124T213007Z
LAST-MODIFIED:20251124T213103Z
UID:10000399-1765843200-1766015999@oncodaily.com
SUMMARY:ESMO Preceptorship on Prostate Cancer 2025: Lugano
DESCRIPTION:The ESMO Preceptorship on Prostate Cancer 2025: Lugano is a two-day educational course focusing on a thorough understanding of prostate cancer management\, from diagnosis to treatment\, according to current standards of care. \nOrganized by the European Society for Medical Oncology (ESMO)\, the event is scheduled to take place on December 16–17\, 2025\, in Lugano\, Switzerland. The preceptorship is designed primarily for medical and clinical oncologists\, especially young oncologists\, and has been accredited for 9 ESMO-MORA category 1 points.
URL:https://oncodaily.com/event/preceptorship-on-prostate-cancer-415823
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/09/1756803627507.jpeg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR